Download
https://www.ndtvprofit.com/business/mylan-biocon-launch-biosimilar-of-cancer-drug-herceptin-in-australia?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Ogivri by Biocon and Mylan is the first trastuzumab biosimilar approved and launched in Australia.
Share